Remdesivir, tocilizumab may be used on severely ill COVID-19 patients
New Delhi: Anti-viral drug ‘remdesivir’ and ‘tocilizumab’, an immunomodulator, are being considered for ‘restricted use’ on severely ill COVID-19 patients ...
Read more
New Delhi: Anti-viral drug ‘remdesivir’ and ‘tocilizumab’, an immunomodulator, are being considered for ‘restricted use’ on severely ill COVID-19 patients ...
Read moreNew Delhi: Glenmark Pharmaceuticals announced Tuesday that it will commence another new Phase 3 clinical trial. This will be on ...
Read moreGeneva: The World Health Organization (WHO), which has come under repeated fire from US President Donald Trump, says the science ...
Read moreBeijing: China has said it is on the verge of developing a new drug which will prevent the spread of ...
Read moreNew Delhi: India has decided to export anti-malarial drug hydroxychloroquine to several countries including those in the neighbourhood on a ...
Read moreBhubaneswar: The Odisha government Wednesday offered incentives for drug and medical equipment suppliers who can ensure supply of these vital ...
Read moreNew Delhi: The Union Health Ministry has recommended use of anti-HIV drug combinations ‘Lopinavir’ and ‘Ritonavir’ on a case-to-case basis ...
Read moreNew Delhi: Twelve more people have tested positive for coronavirus in the country – six in Kerala and three each ...
Read morePanaji: The Entertainment Society of Goa (ESG) is upset with films that seek to portray the tourist hotspot as a ...
Read moreCox’s Bazar (Bangladesh): Dozens of Bangladeshi drug kingpins surrendered in a meth hub along the border with Myanmar, authorities said ...
Read more
I t may appear strange in most democracies, including India, that losing a no-confidence vote against a government leading to...
Read more
The collapse of Bashar al-Assad’s regime in Syria is not an isolated event in the Middle East, but part of...
Read more
The people of South Korea and their representatives showed the world last weekend how real democracy works. The country’s parliament...
Read more
In 2021, I wrote a book called “Price of the Modi Years.” In one of its chapters, I compared India’s...
Read more
